Specificity and clinical utility of methods for the detection of macroprolactin

Clinical Chemistry

Volumn 52, Issue 7, 2006, Pages 1366-1372

  Kavanagh, Lucille ^a,b   McKenna, T Joseph ^a,b   Fahie Wilson, Michael N ^c   Gibney, James ^a   Smith, Thomas P ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c SOUTHEND HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MACROGOL; PROLACTIN; PROTEIN A; PROTEIN G;

ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FEMALE; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HYPERPROLACTINEMIA; IMMUNOASSAY; MALE; SENSITIVITY AND SPECIFICITY; ULTRAFILTRATION;

CHROMATOGRAPHY, GEL; CLINICAL CHEMISTRY TESTS; COSTS AND COST ANALYSIS; HUMANS; IMMUNOASSAY; PROLACTIN; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY;

EID: 33745459047     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.065854     Document Type: Article

References (32)

1. Whittaker PG, Wilcox T, Lind T. Maintained fertility in a patient with hyperprolactinemia due to big, big prolactin. J Clin Endocrinol Metab 1981;53:863-6.
2. Fraser IS, Lun ZG, Zhou JP, Herington AC, McCarron G, Caterson I, et al. Detailed assessment of big big prolactin in women with hyperprolactinemia and normal ovarian function. J Clin Endocrinol Metab 1989;69:585-92.
3. Leite V, Cosby H, Sobrinho LG, Fresnoza MA, Santos MA, Friesen HG. Characterization of big, big prolactin in patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 1992;37:365-72.
4. Fahie-Wilson MN, Soule SG. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 1997;34:252-8.
5. Gibney J, Smith TP, McKenna TJ. Clinical relevance of macroprolactin. Clin Endocrinol (Oxf) 2005;62:633-43.
6. Hattori N, Inagaki C. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. J Clin Endocrinol Metab 1997;82:3107-10.
7. Larrea F, Villanueva C, Carmen Cravioto M, Escorza A, del Real O. Further evidence that big, big prolactin is preferentially secreted in women with hyperprolactinemia and normal ovarian function. Fertil Steril 1985;44:25-30.
8. Smith TP, Suliman AM, Fahie-Wilson MN, McKenna TJ. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 2002;87:5410-5.
9. Schneider W, Marcovitz S, Al-Shammari S, Yago S, Chevalier S. Reactivity of macroprolactin in common automated immunoassays. Clin Biochem 2001;34:469-73.
10. Cavaco B, Prazeres S, Santos MA, Sobrinho LG, Leite V. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays. J Endocrinol Invest 1999;22:203-8.
11. Fahie-Wilson MN. Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin. Clin Chem 2000;46:2022-3.
12. Fahie-Wilson MN, John R, Ellis AR. Macroprolactin; high molecular mass forms of circulating prolactin. Ann Clin Biochem 2005;42:175-92.
13. Olukoga AO, Dornan TL, Kane JW. Three cases of macroprolactinaemia. J R Soc Med 1999;92:342-4.
14. Heaney AP, Laing I, Walton L, Seif MW, Beardwell CG, Davis JR. Misleading hyperprolactinaemia in pregnancy. Lancet 1999;353:720.
15. Quay AT, Sabharwal P, Varma S, Malarkey WB. Delayed diagnosis of psychological erectile dysfunction because of the presence of macroprolactinemia. J Clin Endocrinol Metab 1996;81:2512-4.
16. Cattaneo FA, Fahie-Wilson MN. Concomitant occurrence of macroprolactin, exercise-induced amenorrhea, and a pituitary lesion: a diagnostic pitfall. Case report. J Neurosurg 2001;95:334-7.
17. Suliman AM, Smith TP, Gibney J, McKenna TJ. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem 2003;49:1504-9.
18. Schlechte JA. The macroprolactin problem. J Clin Endocrinol Metab 2002;87:5408-9.
19. Fahie-Wilson M. In hyperprolactinemia, testing for macroprolactin is essential. Clin Chem 2003;49:1434-6.
20. Vieira JG, Tachibana TT, Obara LH, Maciel RM. Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin Chem 1998;44:1758-9.
21. Olukoga AO, Kane JW. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol (Oxf) 1999;51:119-26.
22. Schiettecatte J, De Schepper J, Velkeniers B, Smitz J, Van Steirteghem A. Rapid detection of macroprolactin in the form of prolactin-immunoglobulin G complexes by immunoprecipitation with anti-human IgG-agarose. Clin Chem Lab Med 2001;39:1244-8.
23. Schiettecatte J, Van Opdenbosch A, Anckaert E, De Schepper J, Poppe K, Velkeniers B, et al. Immunoprecipitation for rapid detection of macroprolactin in the form of prolactin-immunoglobulin complexes. Clin Chem 2005;51:1746-8.
24. Sapin R, Kertesz G. Macroprolactin detection by precipitation with protein A-Sepharose: a rapid screening method compared with polyethylene glycol precipitation. Clin Chem 2003;49:502-5.
25. Prazeres S, Santos MA, Ferreira HG, Sobrinho LG. A practical method for the detection of macroprolactinaemia using ultrafiltration. Clin Endocrinol (Oxf) 2003;58:686-90.
26. John R, McDowell IF, Scanlon MF, Ellis AR. Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers. Clin Chem 2000;46:884-5.
27. De Schepper J, Schiettecatte J, Velkeniers B, Blumenfeld Z, Shteinberg M, Devroey P, et al. Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes. Eur J Endocrinol 2003;149:201-7.
28. Fahie-Wilson MN. Polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin Chem 1999;45:436-7.
29. Rogol AD, Rosen SW. Prolactin of apparent large molecular size: the major immunoactive prolactin component in plasma of a patient with a pituitary tumor. J Clin Endocrinol Metab 1974;38:714-7.
30. Tritos NA, Quay AT, Malarkey WB. Asymptomatic 'big' hyperprolactinemia in two men with pituitary adenomas. Eur J Endocrinol 1998;138:82-5.
31. Ellis AR, Fahie-Wilson M. Method recognition of big prolactin in serum and prolactin in amniotic fluid. Edinburgh: UK NEQAS Report 2005;310:1-4.
32. Gibney J, Smith TP, McKenna TJ. The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab 2005;90:3927-32.